Answers are grounded in this paper and cite their sources.
Endolysosomal membrane damage is a detrimental process in mammalian cells that results in leakage of the luminal contents into the cytosol. However, the nature and extent of the leakage during membrane damage are unknown. Here we show that endomembrane damage induces the rapid formation of intraluminal condensates in endolysosomes. A subset of resident luminal proteins undergoes spatially coordinated condensation on endomembrane damage. Electron microscopy reveals distinct luminal morphology, and cryo-electron tomography confirms the compact ultrastructure in their native state. Condensate formation occurs across mechanistically distinct modes of membrane injury, and the condensates are reversibly dissociated on lysosomal recovery. Remarkably, these condensates impose a barrier to endolysosomal escape of therapeutic oligonucleotides. Despite endomembrane damage, luminal oligonucleotide therapeutics are sequestered in damaged endolysosomes through condensate-mediated biophysical immobilization. Targeting condensate sequestration could represent a strategy to improve oligonucleotide-based therapeutics.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: